UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Neurology Peer Reviewers

Anthony A Amato, MD

Professor of Neurology

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Novartis [Myositis]; Acceleron [Muscular dystrophy]; Akashi [Muscular dystrophy]; Strongbridge Pharmaceutical [Periodic paralysis (dichlorphenamide)]; Idera [Dermatomyositis].

Carl W Bazil, MD, PhD

Caitlin Tynan Doyle Professor of Clinical Neurology

Director, Division of Epilepsy and Sleep

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

Carolyn A Bernstein, MD, FAHS

Assistant Professor of Neurology

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Amgen [Headache].

Jose Biller, MD, FACP, FAAN, FAHA

Section Editor — Stroke

Professor of Neurology and Neurological Surgery

Chairman Department of Neurology

Loyola University Chicago

Stritch School of Medicine

Disclosure: Nothing to disclose

Valérie Biousse, MD

Cyrus H. Stoner Professor of Ophthalmology

Professor of Ophthalmology and Neurology

Emory University

Disclosure: Nothing to disclose

Deborah Y Bradshaw, MD

Residency Program Director

Department of Neurology

Upstate Medical University

Disclosure: Grant/Research/Clinical Trial Support: Cytokinetics, Inc [ALS (Tirasemtiv)].

Charles R Cantor, MD

Professor of Clinical Neurology

University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose

Gregory D Cascino, MD

Professor of Neurology

Mayo Clinic, Rochester

Disclosure: Equity Ownership/Stock Options: Received stock through Mayo Foundation, Rochester, MN. (Mayo Medical Ventures) from NEVRO (Redwood City, CA) for SENZA Spinal cord stimulator: chronic intractable back pain (FDA approved).

John de Groot, MD

Professor, Department of Neuro-Oncology

The University of Texas MD Anderson Cancer Center

Disclosure: Grant or Research Support: Sanofi-Aventis [Glioblastoma (XL765)]; Astrazeneca [Glioblastoma (AZD 0156)]; EMD-Serono [Glioblastoma (M2698, Pimasertib)]; Eli Lilly [Glioblastoma (numerous drugs)]; Novartis [Glioblastoma (numerous drugs)]; Deciphera Pharmaceuticals [Glioblastoma (DCC2618, altiratinib)]; Mundipharma [Glioblastoma (EDO-S101)]. Consultant/Advisory Boards: Celldex [Glioblastoma (rindopepimit)]; Deciphera Pharmaceuticals [Glioblastoma (DCC2618, altiratinib)]; AbbVie [Glioblastoma (ABT-414)]; FivePrime Therapeutics, Inc. [Glioblastoma (cabiralizumab)]; Genentech [Glioblastoma (bevacizumab)]; Foundation Medicine, Inc. [Glioblastoma (diagnostics, genomic testing platform)]; Novogen [Glioblastoma (GDC-0084)]; Astrazeneca [Glioblastoma (AZD 0156)]; Insys Therapeutics [Glioblastoma (CBD)]; Kadmon [Glioblastoma (KD019)]; Merck [Glioblastoma (Keytruda)]. Other Financial Interest: VBL Therapeutics [Glioblastoma (VB111)]; Novella [Glioblastoma (ICT-107)].

Vanja Douglas, MD

Assistant Clinical Professor of Neurology

University of California San Francisco School of Medicine

Disclosure: Nothing to disclose

Eric Eggenberger, DO

Professor and Vice-Chairman, Neurology

Michigan State University

Disclosure: Grant/Research/Clinical Trial Support: Biogen [MS (natalizumab)]; Novartis [MS (fingolimod)]. Speaker's Bureau: Genzyme [MS (teriflunomide)]; Novartis [MS (dalfampridine)]; Acorda [MS (fingolimod)]. Consultant/Advisory Boards: Genzyme [MS (teriflunomide)]; Teva [MS (glatiramer)]. Equity Ownership/Stock Options: Lifeblood [MS].

Edward Feldmann, MD

Professor of Neurology

Tufts University School of Medicine

Disclosure: Nothing to disclose

Michael T Fitch, MD, PhD

Assistant Professor, Department of Emergency Medicine

Wake Forest University

Disclosure: Nothing to disclose

Charles C Flippen II, MD

Associate Professor

David Geffen School of Medicine at UCLA

Disclosure: Equity Ownership/Stock Options: Amgen [Headache: (Experimental drug)].

Joseph M Furman, MD, PhD

Professor

University of Pittsburgh

Disclosure: Nothing to disclose

Daniel Harrison, MD

Assistant Professor

University of Maryland School of Medicine

Disclosure: Grant/Research Support: EMD Serono, Inc [Multiple sclerosis (Interferon beta)]. Consultant/Advisory Boards: Genentech [Multiple sclerosis (Rituximab; ocrelizumab)].

Christopher W Hess, MD

Assistant Professor of Neurology

University of Florida

Disclosure: Nothing to disclose

Lawrence J Hirsch, MD

Professor of Neurology

Yale University School of Medicine

Chief

Division of Epilepsy and EEG

Co-Director

Yale Comprehensive Epilepsy Center

Disclosure: Grant/Research/Clinical Trial Support: Upsher-Smith [Epilepsy (Long-acting topiramate, nasal midazolam)]; Eisai [Epilepsy (Perampanel, zonisamide, rufinamide)]. Consultant/Advisory Boards: Monteris [Epilepsy (laser surgery)]; Ceribell [Epilepsy (EEG device)]; Eisai [Epilepsy (perampanel, zonisamide, rufinamide)]; Neuropace [Epilepsy (responsive neurostimulator)]; Sun Pharma [Epilepsy (long acting formulations)]; Engage Therapeutics [Epilepsy (acute benzodiazepine)]. Other Financial Interest: Wiley [Atlas of EEG (Author royalties)]; Medlink Neurology [Epilepsy sections (Author royalties)].

Jonathan Howard, MD

Assistant Professor of Neurology and Psychiatry

NYU Langone School of Medicine

Disclosure: Nothing to disclose

Lara Jehi, MD

Associate Professor

Cleveland Clinic Lerner College of Medicine

Disclosure: Nothing to disclose

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Disclosure: Nothing to disclose

Steven Karceski, MD

Assistant Professor of Neurology

Weill Cornell Medical College

Disclosure: Speaker's Bureau: Cyberonics [Epilepsy (Vagus nerve stimulator)]; Neuropace [Epilepsy (Vagus nerve stimulator)].

Daniel I Kaufer, MD

Chief, Cognitive & Behavioral Neurology

Director, UNC Memory Disorders Program

University of North Carolina at Chapel Hill

Disclosure: Grant/Research/Clinical Trial Support: Abbvie [PSP (8E12 ant-tau antibody)]; TauRx [Memory disorders (LTMT)]; Navidea Biopharmaceuticals [Memory disorders (NAV4694)]; Janssen Research and Development [Memory disorders (Memory test validation)]; Axovant [Memory disorders (RVT-101, nelotanserin)]; Neurim pharmaceuticals [Memory disorders (Piromelatine)]. Consultant/Advisory boards: Takeda [Memory disorders (Pigolitazone)]; Janssen Research and Development [Memory disorders (Memory test validation)]; Axovant [Memory disorders (RVT-101, nelotanserin)].

Christian M Korff, MD

Head, Pediatric Neurology

Geneva University Hospitals

Disclosure: Nothing to disclose

Geoffrey Littlejohn, MD

Associate Professor of Medicine

Monash University, Australia

Disclosure: Speaker's Bureau: Pfizer [Neuropathic pain/fibromyalgia (Pregabalin)].

Andrew L Lux, MSc, PhD, FRCPCH

Consultant in Paediatric Neurology

Bristol Royal Hospital for Children

Disclosure: Nothing to disclose

Kenneth J Mack, MD, PhD

Professor of Neurology and Pediatrics

Mayo Medical School

Disclosure: Consultant/Advisory Boards: Amgen [Headache (Products in development)].

Anil Mendiratta, MD

Associate Professor of Neurology

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

John Miller, MD, PhD

Professor of Neurology and Neurosurgery

Director UW Regional Epilepsy Center

University of Washington

Stephanie Nahas, MD, MDEd

Assistant Professor of Neurology

Thomas Jefferson University

Disclosure: Consultant/Advisory Boards: Supernus [Headache (Trokendi XR)]; Lilly [Headache (drug not yet released, galcanezumab)].

Alison M Pack, MD

Associate Professor of Clinical Neurology

Columbia University College of Physicians and Surgeons

Disclosure: Nothing to disclose

Juliann M Paolicchi, MA, MD

Professor of Clinical Pediatrics

Rutgers Medical School

Disclosure: Grant/Research/Clinical Trial Support: Zogenix [Epilepsy (fenflramine)]. Speaker’s Bureau: Lundbeck Pharm [Epilepsy (Vigabatrin, Clobazam)]; Cyberonics [Epilepsy (VNS)].

Marc C Patterson, MD, FRACP

Section Editor — Pediatric Neurology

Professor of Neurology, Pediatrics, and Medical Genetics

Chair, Division of Child and Adolescent Neurology

Mayo Clinic College of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Vtesse [Niemann-Pick C (Cyclodextrin)]. Consultant/Advisory Boards: Actelion [Niemann-Pick C (Miglustat)]; Agios [CGD]; Alexion [General lysosomal diseases, lysosomal acid lipase deficiency (Sebelipase alfa)]; Amicus [Fabry, Gaucher, Pompe (Migalastat)]; Novartis [MS]; Shire [MLD]. Other Financial Interest: Sage [Honorarium as Editor-in-Chief of Journal of Child Neurology and Child Neurology Open].

Stephen Reich, MD

The Frederick Henry Prince Distinguished Professor in Neurology

The University of Maryland School of Medicine

Disclosure: Nothing to disclose

Michael Ronthal, MD

Professor of Neurology

Harvard Medical School

Disclosure: Nothing to disclose

Sean Ruland, DO

Associate Professor

Loyola University Chicago-Stritch School of Medicine

Disclosure: Nothing to disclose

Steven C Schachter, MD

Professor of Neurology

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: LivaNova, PLC. [Epilepsy (Vagus nerve stimulator)].

David Schiff, MD

Professor of Neurology, Neurological Surgery, and Medicine

University of Virginia School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Cavion, Tocagen, Vascular Biogenics, Stemline [Glioblastoma]. Consultant/Advisory Boards: Genentech [Glioblastoma, oligodendroglioma (bevacizumab)]. Other Financial Interest: Vascular Biogenics (VB-111), Orbus, Monteris.

Duygu Selcen, MD

Associate Professor of Neurology

Mayo Clinic Rochester

Disclosure: Nothing to disclose

Jeremy M Shefner, MD, PhD

Section Editor — Neuromuscular Disease

Professor and Chair of Neurology, Barrow Neurological Institute

Professor of Neurology, University of Arizona, Phoenix

Clinical Professor of Neurology, Creighton University

Disclosure: Grant/Research Support: Biogen Idec; Cytokinetics; Neuraltus [ALS]; Avanir [ALS (Nuedexta)]. Consultant/Advisory Boards: Biogen Idec; Cytokinetics; Ionis; Neuraltus; Mitsubishi Tanabe [ALS]; Edaravone [ALS (MT Pharma)].

Joseph I Sirven, MD

Professor and Chair of Neurology

Mayo Clinic College of Medicine

Disclosure: Nothing to disclose

David E Thaler, MD, PhD, FAHA

Interim Chairman, Department of Neurology

Tufts Medical Center, Tufts University School of Medicine

Disclosure: Consultant/Advisory Boards: St Jude Medical [PFO (Amplatzer PFO Occluder)].

Joshua Z Willey, MD, MS

Assistant Professor of Neurology

Columbia University

Disclosure: Grant/Research/Clinical Trial Support: AstraZeneca [Transient ischemic attack (Ticagrelor)]; Genentech [Minor stroke (Alteplase)]; NIH [Stroke epidemiology]; NIH [Stroke (Clopidogrel)]; Reliant Heart [Clinical Endpoint Committee (Left ventricular assist device)]; Claret Medical [Clinical Endpoint Committee (Embolic protection device in percutaneous aortic valve replacement)]. Consultant/Advisory Boards: HeartWare [Stroke (Ventricular assist device)].